Longevity Investors & VC Firms in Switzerland
14 firms in this list, with a median first check of $1.9M. 4 of them lead rounds. Generated from verified public data and updated continuously.
Maximon
ZugPre-Seed–Series A$11M
22 people
Exelixis Capital
Zürich
3 people
HBM Healthcare Investments
ZugGrowth–Late Stage
7 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
37 people
Unruly Capital
LondonPre-Seed–Series A
3 people
HealthCap
StockholmSeed–Growth
30 people
Apollo Health Ventures
BerlinSeed–Series A
29 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
Kinled Holding
Hong KongSeed–Series A
1 person
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
5 people
Reech Corporations Group
Dubai
10 people
Deep Knowledge Group
LondonSeed
7 people
Frequently asked questions
- Who are the top longevity investors & vc firms in switzerland?
- Top longevity investors & vc firms in switzerland include Maximon, Exelixis Capital, HBM Healthcare Investments, EQT Life Sciences, Unruly Capital, HealthCap, Apollo Health Ventures, Delin Ventures — 14 firms in total meet the criteria.
- What is the typical first check among longevity investors & vc firms in switzerland?
- The median first check among the 14 longevity investors & vc firms in switzerland tracked here is $1.9M.
- How many longevity investors & vc firms in switzerland lead rounds?
- 4 of the 14 longevity investors & vc firms in switzerland tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14074)Investors & VC Firms in United States (13215)Investors & VC Firms in Europe (5565)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4147)SaaS Investors & VC Firms (3842)AI & Machine Learning Investors & VC Firms (3754)Fintech Investors & VC Firms (3710)Investors & VC Firms in Asia-Pacific (3567)Healthtech Investors & VC Firms (3393)
Data sourced from public filings and firms' own websites — see our methodology.















































